Vyvanse supply issues ease

Supply issues impacting ADHD medication Vyvanse are set to return to normal by the end of the month  Takeda Pharmaceuticals Australia is reporting that shortages of Vyvanse (lisdexamfetamine dimesilate) are easing, with supply of the 30mg and 50mg products deemed to have been “resolved”.   However, the company advised the Therapeutic Goods Administration (TGA) that 40mg